# OnCo record lee-jae-lyun (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/lee-jae-lyun/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "lee-jae-lyun" ;
  schema:name "Jae Lyun Lee"@en ;
  schema:description "Jae Lyun Lee is a genitourinary oncologist who brought Korean cohorts into the enfortumab, pembrolizumab, and PARP-inhibitor GU trials."@en ;
  schema:url <https://onco.cc/people/lee-jae-lyun/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://eng.amc.seoul.kr>, <https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20JL%5BAuthor%5D%20Asan%20urothelial> ;
  schema:jobTitle "Professor of Medical Oncology; genitourinary cancers" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/rcc/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/asan-medical-center/> ;
  onco:trials <https://onco.cc/trials/ev-302/>, <https://onco.cc/trials/keynote-426/> ;
  schema:affiliation <https://onco.cc/institutions/asan-medical-center/> .